FDA Recall Open, Classified

Shimadzu Mobile X-Ray System, MobileDaRt Evolution (MX8 Version), with adjustable handle option, Made in Japan - Product Usage: The device is intended to be used to take a film, CR or general radiography of patients in the hospital who cannot move and/or of outpatients in emergency.

Recall: Z-0534-2021 · Initiated November 9, 2020

Recall

Recall Number
Z-0534-2021
Event Number
86734
Firm
Shimadzu Medical Systems
FEI Number
1000125362
Product Code
IZL
Status
Open, Classified
Root Cause
Device Design
Initiated
November 9, 2020
Address
20101 S Vermont Ave, Torrance, CA, 90502-1328

Description

Shimadzu Mobile X-Ray System, MobileDaRt Evolution (MX8 Version), with adjustable handle option, Made in Japan - Product Usage: The device is intended to be used to take a film, CR or general radiography of patients in the hospital who cannot move and/or of outpatients in emergency.

Reason

There is a potential that the adjustable handle option on the X-Ray system may have been installed with improper bolts. This could result in improper driving operation which could lead to harm of individuals around the device.

Action

Shimadzu issued a "Urgent: Voluntary Medical Device Recall Notice" on 11/09/2020" via email. In addition to informing consignees about the recalled device, the notification letter asked consignees to take the following actions: 1. If your unit is on the affected list, then please check the drive handle assembly to see if the bolts have loosened. If you feel there is a problem with the mobile drive and movement, please discontinue use of the system and contact your local service provider. 2. Shimadzu has identified the affected units and informed your authorized service representative. They will be contacting you to schedule time to implement the corrective action. If you do not receive a call or visit concerning this matter, please contact Shimadzu National Support. 3. Please complete the "Medical Device Recall Return Response" form and email to [email protected] 4. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Distribution

US Nationwide distribution including in the states of AL, AZ, CA, FL, GA, IA, IL, IN, KY, LA, MI, MN, MS, NC, ND, NE, NJ, NY, OH, OR, PA, SC, TN, TX, WA, WI.

Quantity

115 units